Publication:
Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion

No Thumbnail Available

Date

1999-08-13

Published Version

Journal Title

Journal ISSN

Volume Title

Publisher

American Society for Biochemistry & Molecular Biology (ASBMB)
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Cherny, Robert A., Jacinta T. Legg, Catriona A. McLean, David P. Fairlie, Xudong Huang, Craig S. Atwood, Konrad Beyreuther et al. "Aqueous Dissolution of Alzheimer’s Disease Aβ Amyloid Deposits by Biometal Depletion." Journal of Biological Chemistry 274, no. 33 (1999): 23223-23228. DOI: 10.1074/jbc.274.33.23223

Research Data

Abstract

Zn(II) and Cu(II) precipitate Aβ in vitro into insoluble aggregates that are dissolved by metal chelators. We now report evidence that these biometals also mediate the deposition of Aβ amyloid in Alzheimer’s disease, since the solubilization of Aβ from post-mortem brain tissue was significantly increased by the presence of chelators, EGTA, N,N,N',N'-tetrakis(2-pyridyl-methyl) ethylene diamine, and bathocuproine. Efficient extraction of Aβ also required Mg(II) and Ca(II). The chelators were more effective in extracting Aβ from Alzheimer’s disease brain tissue than age-matched controls, suggest- ing that metal ions differentiate the chemical architec- ture of amyloid in Alzheimer’s disease. Agents that specifically chelate copper and zinc ions but preserve Mg(II) and Ca(II) may be of therapeutic value in Alzheimer’s disease.

Description

Keywords

Cell Biology, Molecular Biology, Biochemistry

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories